CDNF and Parkinson disease: In 6-OHDA-treated PC12 cells, a cellular model of PD, CDNF treatment increased cell viability through upregulating ratio of anti-apoptotic Bcl-2/pro-apoptotic Bax proteins and downregulating caspase-3 activity, thus resembling the function of NTFs [107].